Pharmaron Beijing Announces Board Reshuffle and Share Cancellation

Pharmaron Beijing Co., Ltd. Class H (HK:3759) has released an update.

Pharmaron Beijing Co., Ltd. announced several strategic changes including the resignation of independent non-executive director Mr. Zhou Qilin and a proposed reshuffle of the board’s composition. Additionally, the company plans to amend its working policy for independent directors and cancel repurchased A shares to reduce its registered capital. These changes are pending approval at the upcoming extraordinary general meeting.

For further insights into HK:3759 stock, check out TipRanks’ Stock Analysis page.